Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Phase 2, Multicenter, Open-Label Study to Assess the Pharmacodynamics, Safety, and Tolerability of DT-168 Ophthalmic Solution in Patients With Fuchs Endothelial Corneal Dystrophy Undergoing Keratoplasty
The purpose of this study is to evaluate the pharmacodynamics, safety, and tolerability of DT-168 Ophthalmic Solution in pre-keratoplasty patients with Fuchs e…
Fuchs Endothelial Corneal DystrophyFuchs
Design Therapeutics, Inc.NCT07024693
Phase 2
Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy
This protocol will investigate whether topical application of N-acetyl cysteine (NAC) eye drops decreases oxidative stress and confers cytoprotection in patien…
Fuchs Endothelial Corneal Dystrophy
Massachusetts Eye and Ear InfirmaryNCT04440280